P-2045 Re-188

DB17204InvestigationalProtein Based Therapies

P-2045 Re-188: Overview.

Mechanism
Curator reviewed
Also known as
Re188 P2045 somatostatin analog · Re188 P2045 somatostatin peptide analogue · Rhenium Re 188-P2045 · Rhenium Re-188 P-2045 · Rhenium Re-188 P2045
Code names
BAY-86-5284 · P-2045 RE-188 · RE188-P2045

Resolves to

Compound
UNII2H4MY43GJDCAS934712-65-9
Targets
P30874SSTR2

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with P-2045 Re-188, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In